Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing

被引:98
作者
Arendrup, Maiken Cavling [1 ]
Garcia-Effron, Guillermo [2 ]
Buzina, Walter [3 ]
Mortensen, Klaus Leth [1 ]
Reiter, Nanna [4 ]
Lundin, Christian [1 ]
Jensen, Henrik Elvang [5 ]
Lass-Florl, Cornelia [6 ]
Perlin, David S. [2 ]
Bruun, Brita [7 ]
机构
[1] Statens Serum Inst, Unit Mycol & Parasitol, DK-2300 Copenhagen S, Denmark
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA
[3] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria
[4] Roskilde Hosp, Dept Intens Care Med, Roskilde, Denmark
[5] Univ Copenhagen, Fac Life Sci, Dept Dis Biol, Copenhagen, Denmark
[6] Innsbruck Med Univ, Dept Hyg & Med Microbiol, Innsbruck, Austria
[7] Cent Hosp Hillerod, Dept Clin Microbiol, Hillerod, Denmark
关键词
BROTH MICRODILUTION METHOD; IN-VITRO SUSCEPTIBILITY; EUROPEAN-COMMITTEE; INVASIVE ASPERGILLOSIS; REDUCED SUSCEPTIBILITY; GLOBAL SURVEILLANCE; ECHINOCANDIN DRUGS; SYSTEMIC MYCOSES; AFST-EUCAST; RESISTANCE;
D O I
10.1128/AAC.01292-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Caspofungin is used for the treatment of acute invasive candidiasis and as salvage treatment for invasive aspergillosis. We report characteristics of isolates of Candida albicans and Aspergillus fumigatus detected in a patient with breakthrough infection complicating severe gastrointestinal surgery and evaluate the capability of susceptibility methods to identify candin resistance. The susceptibility of C. albicans to caspofungin and anidulafungin was investigated by Etest, microdilution (European Committee on Antibiotic Susceptibility Testing [ EUCAST] and CLSI), disk diffusion, agar dilution, and FKS1 sequencing and in a mouse model. Tissue was examined by immunohistochemistry, PCR, and sequencing for the presence of A. fumigatus and resistance mutations. The MICs for the C. albicans isolate were as follows: > 32 mu g/ml caspofungin and 0.5 mu g/ml anidulafungin by Etest, 2 mu g/ml caspofungin and 0.125 mu g/ml anidulafungin by EUCAST methods, and 1 mu g/ml caspofungin and 0.5 mu g/ml anidulafungin by CLSI methods. Sequencing of the FKS1 gene revealed a mutation leading to an S645P substitution. Caspofungin and anidulafungin failed to reduce kidney CFU counts in animals inoculated with this isolate (P > 0.05 compared to untreated control animals), while both candins completely sterilized the kidneys in animals infected with a control isolate. Disk diffusion and agar dilution methods clearly separated the two isolates. Immunohistochemistry and sequencing confirmed the presence of A. fumigatus without FSK1 resistance mutations in liver and lung tissues. Breakthrough disseminated aspergillosis and candidiasis developed despite an absence of characteristic FKS1 resistance mutations in the Aspergillus isolates. EUCAST and CLSI methodology did not separate the candin-resistant clinical isolate from the sensitive control isolate as well as did the Etest and agar methods.
引用
收藏
页码:1185 / 1193
页数:9
相关论文
共 50 条
  • [1] Aspergillus section fumigati:: Antifungal susceptibility patterns and sequence-based identification
    Alcazar-Fuoli, Laura
    Mellado, Emilia
    Alastruey-Izquierdo, Ana
    Cuenca-Estrella, Manuel
    Rodriguez-Tudela, Juan L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1244 - 1251
  • [2] Comparative evaluation of etest and sensititre YeastOne panels against the clinical and laboratory standards institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents
    Alexander, Barbara D.
    Byrne, Terry C.
    Smith, Kelly L.
    Hanson, Kimberly E.
    Anstrom, Kevin J.
    Perfect, John R.
    Reller, L. Barth
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) : 698 - 706
  • [3] [Anonymous], 1990, PCR Protocols. A Guide to Methods and Applications
  • [4] Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility
    Arendrup, M. C.
    Fuursted, K.
    Gahrn-Hansen, B.
    Schonheyder, H. C.
    Knudsen, J. D.
    Jensen, I. M.
    Bruun, B.
    Christensen, J. J.
    Johansen, H. K.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (05) : 487 - 494
  • [5] Establishing in vitro-in vivo correlations for Aspergillus fumigatus:: the challenge of azoles versus echinocandins
    Arendrup, Maiken Cavling
    Perkhofer, Susanne
    Howard, Susan J.
    Garcia-Effron, Guillermo
    Vishukumar, Aimanianda
    Perlin, David
    Lass-Floerl, Cornelia
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) : 3504 - 3511
  • [6] Acquired resistance to echinocandins in Candida albicans:: case report and review
    Baixench, Marie-Therese
    Aoun, Naji
    Desnos-Ollivier, Marie
    Garcia-Hermoso, Dea
    Bretagne, Stephane
    Ramires, Sandrine
    Piketty, Christophe
    Dannaoui, Eric
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1076 - 1083
  • [7] Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species
    Chryssanthou, E
    Cuenca-Estrella, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3841 - 3844
  • [8] Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
    Cuenca-Estrella, M.
    Arendrup, M. C.
    Chryssanthou, E.
    Dannaoui, E.
    Lass-Florl, C.
    Sandven, P.
    Velegraki, A.
    Rodriguez-Tudela, J. L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (10) : 1018 - 1022
  • [9] Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
    Cuenca-Estrella, M
    Moore, CB
    Barchiesi, F
    Bille, J
    Chryssanthou, E
    Denning, DW
    Donnelly, JP
    Dromer, F
    Dupont, B
    Rex, JH
    Richardson, MD
    Sancak, B
    Verweij, PE
    Rodríguez-Tudela, JL
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (06) : 467 - 474
  • [10] Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
    Dellinger, R. Phillip
    Levy, Mitchell M.
    Carlet, Jean M.
    Bion, Julian
    Parker, Margaret M.
    Jaeschke, Roman
    Reinhart, Konrad
    Angus, Derek C.
    Brun-Buisson, Christian
    Beale, Richard
    Calandra, Thierty
    Dhainaut, Jean-Francois
    Gerlach, Herwig
    Harvey, Maurene
    Marini, John J.
    Marshall, John
    Ranieri, Marco
    Ramsay, Graham
    Sevransky, Jonathan
    Thompson, B. Taylor
    Townsend, Sean
    Vender, Jeffrey S.
    Zimmerman, Janice L.
    Vincent, Jean-Louis
    [J]. CRITICAL CARE MEDICINE, 2008, 36 (01) : 296 - 327